It’s becoming increasingly clear that minimal signal detection is not cutting it, when it comes to doing the best for patients and staying ahead of... The post Statistical Significance: Could Small Pharma Companies be making more of Safety Signal Detection? appeared first on .|
It turns out that AI really is doing the work. At least a growing chunk of it. Artificial intelligence is spreading through the global workforce like wildfire, dwarfing the adoption pace of the internet, with a new Anthropic report citing Gallup research that 40% of U.S. employees now use AI at work. While the field… The post As the pharma industry grapples with a talent shortfall, AI makes inroads in drug-safety workflows appeared first on Drug Discovery and Development.| Drug Discovery and Development
Effective long-term follow-up in vaccine clinical trials is crucial. Explore key considerations for study design, patient tokenization, and regulatory compliance.| Drug Discovery and Development
Boston, 23rd July 2025: The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, is launching two complementary initiatives to transform pharmacovigilance (PV) in response to growing member demand. A new dedicated AI in Safety & PV Community of Experts (CoE) will explore how to apply AI safely, ethically and effectively within pharmacovigilance workflows.| Pistoia Alliance
